⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9614 | 0.97 | — | — | |
| SCHEMBL15732276 | 0.97 | — | — | |
| SCHEMBL5370 | 0.97 | — | — | |
| SCHEMBL9460 | 0.93 | — | — | |
| SCHEMBL27801111 | 0.93 | — | — | |
| SCHEMBL19205215 | 0.90 | — | — | |
| SCHEMBL17435811 | 0.90 | — | — | |
| Ammonia Solution, Strong SCHEMBL9387734 | 0.90 | — | — | |
| SCHEMBL1030444 | 0.90 | — | — | |
| SCHEMBL5090161 | 0.90 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7550613-B2 | alpha-methoxy docosahexanoic acid ethyl ester, alpha-iodo-docosahexanoic acid ethyl ester; antidiabetic for diabetes type 2, cardiovascular disorders, obesity, amyloidosis, prophylaxis; free of 4,7,10,13,16,19-docosahexanoic acid ( DHA), alpha-methyl DHA, alpha-methyl DHA-methyl ester | PRONOVA BIOPHARMA NORGE AS (NO) | 2009-06-23 | — | — | US | disclosed |